eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 15/07/2011
PIL Neurontin Capsules and Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/03/2010 and displayed until 15/07/2011
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 09/03/2010 and displayed until 22/03/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 28/01/2009 and displayed until 09/03/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/12/2008 and displayed until 28/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/08/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to side-effects
  • Change due to user-testing of patient information
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 23/10/2007 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 08/12/2006 and displayed until 23/10/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 23/11/2005 and displayed until 08/12/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   gabapentin